AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33162329 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation (pre-exercise: 0.084 g kg−1 BW; during exercise: 0.056 g kg−1 h−1)
Number of subjects: 18
Study 33162329 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution (non-caloric)
Number of subjects: 18
Study 32213084 — intervention group
Group type: EXPERIMENTAL
Intervention: Freezing at -20°C
Number of subjects: 2
Study 32213084 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-drying
Number of subjects: 2
Study 32213084 — intervention group
Group type: EXPERIMENTAL
Intervention: Freezing at -80°C
Number of subjects: 2
Study 32213084 — intervention group
Group type: EXPERIMENTAL
Intervention: Freezing at -196°C
Number of subjects: 2
Study 616796775 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified surgical technique for repair of complex vesicovaginal fistulas
Number of subjects: 29
Study 616796775 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgical technique for repair of complex vesicovaginal fistulas
Number of subjects: 29
Study 36221338 — intervention group
Group type: EXPERIMENTAL
Intervention: Phellinus linteus extract 1000 mg per day
Number of subjects: 30
Study 36221338 — intervention group
Group type: EXPERIMENTAL
Intervention: Phellinus linteus extract 2000 mg per day
Number of subjects: 30
Study 36221338 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2000 mg of dextrin per day)
Number of subjects: 30
Study 32690741 — intervention group
Group type: EXPERIMENTAL
Intervention: High occupational stress (ERI score >1)
Number of subjects: 1400
Study 32690741 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe depression
Number of subjects: 1400
Study 32690741 — intervention group
Group type: EXPERIMENTAL
Intervention: Job burn-out
Number of subjects: 1400
Study 32690741 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 1400
Study 32690741 — intervention group
Group type: EXPERIMENTAL
Intervention: Working years
Number of subjects: 1400
Study 34561872 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume Foley catheter (60 ml) and vaginal misoprostol
Number of subjects: 100
Study 32749459 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary administration of allogeneic cardiosphere-derived cells (CDCs)
Number of subjects: 134
Study 32749459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 33316099 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation using collagenated bovine bone mineral and a resorbable collagen membrane (RP)
Number of subjects: 26
Study 33316099 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous healing (SH)
Number of subjects: 26
Study 33126051 — intervention group
Group type: EXPERIMENTAL
Intervention: More precise dosing with 0.5 mg acenocoumarol increments
Number of subjects: 80
Study 33126051 — intervention group
Group type: COMPARATOR
Intervention: Conventional dosing with 1.0 mg acenocoumarol increments
Number of subjects: 80
Study 35982162 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12 supplementation (1000 µg cyanocobalamin per day for 12 weeks)
Number of subjects: 40
Study 35982162 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12 supplementation
Number of subjects: 40
Study 35982162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34341098 — intervention group
Group type: EXPERIMENTAL
Intervention: Rare PCSK9/APOB variant carriers
Number of subjects: 13131
Study 34341098 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSK9 R46L variant heterozygotes
Number of subjects: 13131
Study 34341098 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSK9 R46L variant homozygotes
Number of subjects: 13131
Study 34341098 — intervention group
Group type: COMPARATOR
Intervention: Non-carriers
Number of subjects: 13131
Study 34341098 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 13131
Study 32157328 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch (21 mg)
Number of subjects: 81
Study 32157328 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch (0 mg)
Number of subjects: 81
Study 32672515 — intervention group
Group type: EXPERIMENTAL
Intervention: MINDSTRONG© cognitive‐behavioral skills building program
Number of subjects: 201
Study 32672515 — intervention group
Group type: COMPARATOR
Intervention: Attention control program
Number of subjects: 201
Study 33707426 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy intervention group (HIG)
Number of subjects: 60
Study 33707426 — intervention group
Group type: EXPERIMENTAL
Intervention: Light intervention group (LIG)
Number of subjects: 60
Study 33707426 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study 35554396 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Cannabidiol (CBD) 25mg
Number of subjects: 0
Study 35554396 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Cannabidiol (CBD) 50mg
Number of subjects: 0
Study 35554396 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Cannabidiol (CBD) 200mg
Number of subjects: 0
Study 35554396 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0mg CBD)
Number of subjects: 0
Study 32568136 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEK post
Number of subjects: 36
Study 32568136 — intervention group
Group type: EXPERIMENTAL
Intervention: PIC post
Number of subjects: 36
Study 32568136 — intervention group
Group type: EXPERIMENTAL
Intervention: FRC post
Number of subjects: 36
Study 36305845 — intervention group
Group type: EXPERIMENTAL
Intervention: Online yoga intervention
Number of subjects: 72
Study 36305845 — intervention group
Group type: COMPARATOR
Intervention: Podcast control
Number of subjects: 72
Study 33656064 — intervention group
Group type: EXPERIMENTAL
Intervention: ART restorations using High Viscosity Glass‐ionomer cement (HVGIC)
Number of subjects: 54
Study 33656064 — intervention group
Group type: COMPARATOR
Intervention: Conventional restorations using resin composite
Number of subjects: 54
Study 36173237 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP) with insulin aspart or insulin lispro
Number of subjects: 165
Study 36173237 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP)
Number of subjects: 165
Study 36173237 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 165
Study 35284389 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized educational and behavioral interventions through the EMPOWER app
Number of subjects: 0
Study 35284389 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical care
Number of subjects: 0
Study 32248163 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiseptic solution 'Decasan'; probiotic 'BioGaia ProDentis'; immune modulator 'Imupret'
Number of subjects: 0
Study 32248163 — intervention group
Group type: COMPARATOR
Intervention: Common treatment scheme (control group)
Number of subjects: 0
Study 36367997 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 cycles of adjuvant fluorouracil, leucovorin, and oxaliplatin chemotherapy
Number of subjects: 2450
Study 36367997 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercising ≥ 9 MET-hours per week after treatment
Number of subjects: 2450
Study 36367997 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥ 25
Number of subjects: 2450
Study 36367997 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 2450
Study 33421928 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone therapy (ozonized rectal insufflation and minor auto haemotherapy) along with standard of care (SOC)
Number of subjects: 60
Study 33421928 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 60
Study 35411007 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended cooking oils rich in omega-3 alpha-linolenic acid and phytonutrients
Number of subjects: 126
Study 35411007 — intervention group
Group type: COMPARATOR
Intervention: Refined olive oil
Number of subjects: 126
Study 35411007 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil blend with highest concentration of omega-3 PUFA
Number of subjects: 126
Study 33415448 — intervention group
Group type: EXPERIMENTAL
Intervention: 14Fr pigtail catheters (PCs)
Number of subjects: 43
Study 33415448 — intervention group
Group type: COMPARATOR
Intervention: 28-32Fr chest tubes (CTs)
Number of subjects: 43
Study 32020853 — intervention group
Group type: EXPERIMENTAL
Intervention: A. konjac extract capsules (5 mg glycosylceramides)
Number of subjects: 51
Study 32020853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 34699271 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral surgery (TOS) plus 66 Gy postoperative radiation therapy (RT) and weekly cisplatin
Number of subjects: 495
Study 34699271 — intervention group
Group type: COMPARATOR
Intervention: Observation (no treatment)
Number of subjects: 495
Study 33140566 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 182
Study 33140566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study 32977232 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical care admission
Number of subjects: 825
Study 32977232 — intervention group
Group type: COMPARATOR
Intervention: No critical care admission (Control)
Number of subjects: 825
Study 35105558 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture group
Number of subjects: 330
Study 35105558 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture group
Number of subjects: 330
Study 35105558 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 330
Study 33940126 — intervention group
Group type: EXPERIMENTAL
Intervention: Acromioplasty
Number of subjects: 90
Study 33940126 — intervention group
Group type: COMPARATOR
Intervention: Nonacromioplasty
Number of subjects: 90
Study 32907900 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedical lifestyle intervention programme
Number of subjects: 850
Study 32907900 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 850
Study 35691777 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxygenated fatty acids (HFA)
Number of subjects: 0
Study 35691777 — intervention group
Group type: COMPARATOR
Intervention: Extra-virgin olive oil (EVOO)
Number of subjects: 0
Study 33814051 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 100
Study 33814051 — intervention group
Group type: COMPARATOR
Intervention: Orthosis
Number of subjects: 100
Study 35901049 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean-Cook ethanol stoves used for 156 days
Number of subjects: 324
Study 35901049 — intervention group
Group type: COMPARATOR
Intervention: Kerosene/firewood users (control)
Number of subjects: 324
Study 34797886 — intervention group
Group type: EXPERIMENTAL
Intervention: BPT
Number of subjects: 16
Study 34797886 — intervention group
Group type: COMPARATOR
Intervention: BPTbounce
Number of subjects: 16
Study 32966703 — intervention group
Group type: EXPERIMENTAL
Intervention: Custard
Number of subjects: 12
Study 32966703 — intervention group
Group type: EXPERIMENTAL
Intervention: Sponge cake
Number of subjects: 12
Study 32966703 — intervention group
Group type: COMPARATOR
Intervention: Pudding
Number of subjects: 12
Study 32966703 — intervention group
Group type: COMPARATOR
Intervention: Biscuit
Number of subjects: 12
Study 32966703 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 12
Study 32966703 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein
Number of subjects: 12
Study 35855385 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving skills training (one session per week for four weeks)
Number of subjects: 105
Study 35855385 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-awareness skills training (one session per week for four weeks)
Number of subjects: 105
Study 35855385 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 105
Study 33843410 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-immersive Virtual Reality navigation therapy (vSail-Access®), 30-40 min per day, three times per week for six weeks
Number of subjects: 11
Study 33843410 — intervention group
Group type: COMPARATOR
Intervention: Control group (rehabilitation programmed by the hospital)
Number of subjects: 11
Study 36878996 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (1200 mg twice daily)
Number of subjects: 31
Study 36878996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 36878996 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 31
Study 33682983 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 10 mg/kg daily divided into 2 doses every 12 h
Number of subjects: 40
Study 33682983 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 40
Study 33682983 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 40
Study 35006266 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous edaravone
Number of subjects: 324
Study 35006266 — intervention group
Group type: COMPARATOR
Intervention: Riluzole only (standard therapy)
Number of subjects: 324
Study 33495732 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical exercise trial participation
Number of subjects: 16
Study 35749997 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 5 mg/kg
Number of subjects: 198
Study 35749997 — intervention group
Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 198
Study 33954850 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment (NSPT) in the +PE+RA group
Number of subjects: 66
Study 33954850 — intervention group
Group type: COMPARATOR
Intervention: Individuals with RA (with and without PE) compared to controls
Number of subjects: 66
Study 35709376 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 4 mg suppository
Number of subjects: 577
Study 35709376 — intervention group
Group type: COMPARATOR
Intervention: Budesonide 2 mg foam
Number of subjects: 577
Study 32044205 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartWare LVAD (HVAD)
Number of subjects: 604
Study 34957959 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual mirror therapy (BMT)
Number of subjects: 28
Study 34957959 — intervention group
Group type: COMPARATOR
Intervention: Unimanual mirror therapy (UMT)
Number of subjects: 28
Study 36239702 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam-Fentanyl (M-F)
Number of subjects: 58
Study 36239702 — intervention group
Group type: COMPARATOR
Intervention: Midazolam-Ketamine (M-K)
Number of subjects: 58
Study 34246483 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndesmosis screw fixation (SS)
Number of subjects: 43
Study 34246483 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture button (SB)
Number of subjects: 43
Study 33586572 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended labor group (at least 1 additional hour in the second stage if undelivered after three hours)
Number of subjects: 34
Study 33586572 — intervention group
Group type: COMPARATOR
Intervention: Usual labor group (expedited delivery after three hours in the second stage)
Number of subjects: 34
Study 33586572 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended labor group
Number of subjects: 34
Study 33586572 — intervention group
Group type: COMPARATOR
Intervention: Usual labor group
Number of subjects: 34
Study 34021093 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-neck precooling
Number of subjects: 8
Study 34021093 — intervention group
Group type: COMPARATOR
Intervention: No head-neck precooling
Number of subjects: 8
Study 35384302 — intervention group
Group type: EXPERIMENTAL
Intervention: Heartfulness Self-Care program (4-week duration)
Number of subjects: 108
Study 35384302 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-listed)
Number of subjects: 108
Study 32701637 — intervention group
Group type: EXPERIMENTAL
Intervention: 10‐Hz repetitive transcranial magnetic stimulation to left dorsolateral prefrontal cortex
Number of subjects: 20
Study 32701637 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study 32941610 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization out of bed immediately after abdominal surgery
Number of subjects: 23
Study 33297826 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete Decongestive Therapy (CDT) plus exercises
Number of subjects: 33
Study 33297826 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression Therapy (IPCT) plus exercises
Number of subjects: 33
Study 33297826 — intervention group
Group type: COMPARATOR
Intervention: Exercises alone (Control)
Number of subjects: 33
Study 33027531 — intervention group
Group type: EXPERIMENTAL
Intervention: BPV-BCD
Number of subjects: 78
Study 33027531 — intervention group
Group type: COMPARATOR
Intervention: plain BPV
Number of subjects: 78
Study 36409969 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD oil (100 mg/mL, 0.5 mL once daily to 2 mL three times a day)
Number of subjects: 144
Study 36409969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 36409969 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD oil
Number of subjects: 144
Study 36409969 — intervention group
Group type: COMPARATOR
Intervention: CBD oil and Placebo
Number of subjects: 144
Study 32483847 — intervention group
Group type: EXPERIMENTAL
Intervention: Prucalopride
Number of subjects: 20
Study 32483847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 33287715 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned Pain Modulation (CPM)
Number of subjects: 38
Study 33287715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Distraction (1-back task)
Number of subjects: 38
Study 35346273 — intervention group
Group type: EXPERIMENTAL
Intervention: Publications related to ONFH
Number of subjects: 2594
Study 35346273 — intervention group
Group type: EXPERIMENTAL
Intervention: Publications from China, USA, and Japan
Number of subjects: 2594
Study 35346273 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis of publications
Number of subjects: 2594
Study 35346273 — intervention group
Group type: EXPERIMENTAL
Intervention: Keywords categorized into four clusters
Number of subjects: 2594
Study 35346273 — intervention group
Group type: EXPERIMENTAL
Intervention: Research hotspots
Number of subjects: 2594
Study 35346273 — intervention group
Group type: EXPERIMENTAL
Intervention: Future research focuses
Number of subjects: 2594
Study 34447275 — intervention group
Group type: EXPERIMENTAL
Intervention: In-house manikin
Number of subjects: 37
Study 34447275 — intervention group
Group type: COMPARATOR
Intervention: Commercial manikin
Number of subjects: 37
Study 33215652 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaf group (expansion screw with Ni-Ti springs)
Number of subjects: 56
Study 33215652 — intervention group
Group type: COMPARATOR
Intervention: RME group (conventional RME screw)
Number of subjects: 56
Study 33215652 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaf group
Number of subjects: 56
Study 33215652 — intervention group
Group type: COMPARATOR
Intervention: RME group
Number of subjects: 56
Study 34643020 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 149
Study 34643020 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine U100
Number of subjects: 149
Study 33756252 — intervention group
Group type: EXPERIMENTAL
Intervention: PARS intervention (12–15 sessions)
Number of subjects: 30
Study 33756252 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 32825020 — intervention group
Group type: EXPERIMENTAL
Intervention: Glo
Number of subjects: 0
Study 32825020 — intervention group
Group type: EXPERIMENTAL
Intervention: Iqos
Number of subjects: 0
Study 32825020 — intervention group
Group type: EXPERIMENTAL
Intervention: Juul
Number of subjects: 0
Study 32825020 — intervention group
Group type: COMPARATOR
Intervention: TCC
Number of subjects: 0
Study 32825020 — intervention group
Group type: COMPARATOR
Intervention: Glo vs Iqos
Number of subjects: 0
Study 32825020 — intervention group
Group type: COMPARATOR
Intervention: Glo vs Juul
Number of subjects: 0
Study 32825020 — intervention group
Group type: COMPARATOR
Intervention: Iqos vs Juul
Number of subjects: 0
Study 35334791 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-fat (LCHF) diet (6/69/25% en carbohydrate/fat/protein)
Number of subjects: 7
Study 35334791 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate/low-fat (HCLF) diet (57/28/15% en carbohydrate/fat/protein)
Number of subjects: 7
Study 33166694 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 800 mg on Day 1 followed by 400 mg once weekly for 3 weeks
Number of subjects: 317
Study 33166694 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HCQ)
Number of subjects: 317
Study 33166694 — intervention group
Group type: EXPERIMENTAL
Intervention: PEP with HCQ
Number of subjects: 317
Study 35285904 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% hydrogen peroxide bleaching treatment
Number of subjects: 72
Study 35285904 — intervention group
Group type: COMPARATOR
Intervention: Placebo agent
Number of subjects: 72
Study 36202320 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee consumption
Number of subjects: 48
Study 36202320 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated coffee consumption
Number of subjects: 48
Study 32703096 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced shooters (ES) in High Social Inhibition (Hi SI)
Number of subjects: 0
Study 32703096 — intervention group
Group type: EXPERIMENTAL
Intervention: Novice shooters (NS) in High Social Inhibition (Hi SI)
Number of subjects: 0
Study 32703096 — intervention group
Group type: COMPARATOR
Intervention: Novice shooters (NSL)
Number of subjects: 0
Study 32703096 — intervention group
Group type: COMPARATOR
Intervention: Experienced shooters (ESL)
Number of subjects: 0
Study 32792098 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial neural network model
Number of subjects: 353
Study 35441839 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy CT (DECT) (n = 40, 80/Sn150 kV, ref. mAs tube A 91/tube B 61)
Number of subjects: 80
Study 35441839 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy CT (DECT) (n = 40)
Number of subjects: 80